TRG has an overarching policy on antibiotics focused only on critically important antibiotics to human medicine that covers all relevant species, markets and suppliers. We welcome their positive engagement on the issue, however, in terms of implementation, the company continues to be at the early stages of collecting data from its suppliers including mapping the supply chain of their most recent acquisition – Wagamama. This will inform the development of relevant time-bound commitments. The company has yet to publicly report on implementation progress, and it continues to monitor supplier compliance through internal audits only.
We are encouraged by TRG’s commitment to antibiotics stewardship. However, we would encourage the company to further strengthen their programme by:
- Extending the scope of their policy beyond critically important antibiotics in order to phase out the routine use of all antibiotics and/ or only use antibiotics when there is a disease present and administered by a veterinarian.
- Setting target and timelines for implementation across all relevant species sourced.
- Committing to third-party audits across all relevant markets and species to ensure supplier compliance.
- Reporting more comprehensively and publicly on implementation progress including antibiotics use.
Our animal welfare policy references antibiotic use in growing and husbandry systems and only permits use under veterinary control for medical condition treatment. No growth promoting agents are permitted, this is in line with EU and 3rd country supply. We continue to work with our supply chains to deliver welfare, environmental and quality benefits to our guests, employees and stakeholders.
See the company response to our engagement here.